{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T09:31:28Z","timestamp":1793266288580,"version":"4.5.0"},"reference-count":47,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/100006314","name":"Biogen Idec","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006314","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015277","name":"Roche Products","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015277","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuromuscular Diseases"],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:p>\n                    Adult SMA REACH is a\n                    <jats:bold>Re<\/jats:bold>\n                    search and\n                    <jats:bold>C<\/jats:bold>\n                    linical\n                    <jats:bold>H<\/jats:bold>\n                    ub in the UK that established a collaborative clinical network for Spinal Muscular Atrophy (SMA) in 2020 across 19 clinical sites, patient advocacy groups, regulators, and industry. In recent years, the treatment landscape in the SMA setting has rapidly evolved with Nusinersen and Risdiplam receiving conditional approval via a Managed Access Agreement (MAA) in the UK. Here we describe the structure of a Real-World Data (RWD) collection study implemented to collect standardised outcome measures to inform on the natural history of the disease and the impact of novel treatments. The study also reports data to The National Institute for Health and Care Excellence (NICE) and NHS England (NHSE) for the purpose of the MAA's. The Adult SMA REACH database currently contains data from 466 patients and 2255 visits, with more than 8000 functional outcome measure assessments. Adult SMA REACH provides insights into how real-world data can be used to evaluate treatment outcomes in rare diseases, where conducting randomised controlled trials may be difficult. The registry also offers an infrastructure that supports collaborative research and reduces data silos. In this paper we describe the complexity of establishing such a study and clinical network including considerations for adapting this model to other disease areas. Further information on the Adult SMA REACH data collection study and clinical network can be found on the website (\n                    <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/adultsmareach.co.uk\/\">https:\/\/adultsmareach.co.uk\/<\/jats:ext-link>\n                    ) and ClinicalTrials.gov (NCT06978985,\n                    <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/study\/NCT06978985\">https:\/\/clinicaltrials.gov\/study\/NCT06978985<\/jats:ext-link>\n                    ).\n                  <\/jats:p>","DOI":"10.1177\/22143602261433509","type":"journal-article","created":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T05:47:43Z","timestamp":1773467263000},"page":"1252-1262","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Adult SMA REACH: A UK clinical network and real-world data collection study for adults living with spinal muscular atrophy"],"prefix":"10.1177","volume":"13","author":[{"given":"Jess","family":"Page","sequence":"first","affiliation":[{"name":"John Walton Muscular Dystrophy Research Centre, Newcastle University &amp; Newcastle Hospitals NHS Trust, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Karkkainen","sequence":"additional","affiliation":[{"name":"John Walton Muscular Dystrophy Research Centre, Newcastle University &amp; Newcastle Hospitals NHS Trust, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Segovia","sequence":"additional","affiliation":[{"name":"John Walton Muscular Dystrophy Research Centre, Newcastle University &amp; Newcastle Hospitals NHS Trust, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Fitzsimmons","sequence":"additional","affiliation":[{"name":"John Walton Muscular Dystrophy Research Centre, Newcastle University &amp; Newcastle Hospitals NHS Trust, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5631-0030","authenticated-orcid":false,"given":"Jose","family":"Verdu-Diaz","sequence":"additional","affiliation":[{"name":"John Walton Muscular Dystrophy Research Centre, Newcastle University &amp; Newcastle Hospitals NHS Trust, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2933-5440","authenticated-orcid":false,"given":"Lindsay","family":"Murphy","sequence":"additional","affiliation":[{"name":"John Walton Muscular Dystrophy Research Centre, Newcastle University &amp; Newcastle Hospitals NHS Trust, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grecia","family":"Benesperi","sequence":"additional","affiliation":[{"name":"John Walton Muscular Dystrophy Research Centre, Newcastle University &amp; Newcastle Hospitals NHS Trust, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksander","family":"Carver","sequence":"additional","affiliation":[{"name":"John Walton Muscular Dystrophy Research Centre, Newcastle University &amp; Newcastle Hospitals NHS Trust, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Simms","sequence":"additional","affiliation":[{"name":"John Walton Muscular Dystrophy Research Centre, Newcastle University &amp; Newcastle Hospitals NHS Trust, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Tanner","sequence":"additional","affiliation":[{"name":"John Walton Muscular Dystrophy Research Centre, Newcastle University &amp; Newcastle Hospitals NHS Trust, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Tasca","sequence":"additional","affiliation":[{"name":"John Walton Muscular Dystrophy Research Centre, Newcastle University &amp; Newcastle Hospitals NHS Trust, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dionne","family":"Moat","sequence":"additional","affiliation":[{"name":"John Walton Muscular Dystrophy Research Centre, Newcastle University &amp; Newcastle Hospitals NHS Trust, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jassi","family":"Michell-Sodhi","sequence":"additional","affiliation":[{"name":"John Walton Muscular Dystrophy Research Centre, Newcastle University &amp; Newcastle Hospitals NHS Trust, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert Muni","family":"Lofra","sequence":"additional","affiliation":[{"name":"John Walton Muscular Dystrophy Research Centre, Newcastle University &amp; Newcastle Hospitals NHS Trust, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Marini-Bettolo","sequence":"additional","affiliation":[{"name":"John Walton Muscular Dystrophy Research Centre, Newcastle University &amp; Newcastle Hospitals NHS Trust, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the Adult SMA REACH clinical network","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,3,13]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-022-00380-8"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9072222"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.24497"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.27519"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.3233\/JND-200611"},{"key":"e_1_3_3_7_2","unstructured":"Agency EM. New gene therapy to treat spinal muscular atrophy 2020 [Available from: https:\/\/www.ema.europa.eu\/en\/news\/new-gene-therapy-treat-spinal-muscular-atrophy-corrected."},{"key":"e_1_3_3_8_2","unstructured":"Excellence NIfHaC. Risdiplam for treating spinal muscular atrophy 2021 [Available from: https:\/\/www.nice.org.uk\/guidance\/ta755."},{"key":"e_1_3_3_9_2","unstructured":"Excellence NIfHaC. Nusinersen for treating spinal muscular atrophy 2019 [Available from: https:\/\/www.nice.org.uk\/guidance\/ta588\/evidence."},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2016.09.922"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2017.11.004"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2017.11.005"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1177\/0883073807305788"},{"key":"e_1_3_3_14_2","first-page":"13","article-title":"Real-World data on access to standards of care for people with spinal muscular atrophy in the UK","volume":"30","author":"Muni-Lofra R","year":"2022","unstructured":"Muni-Lofra R, Murphy LB, Adcock K, et al. Real-World data on access to standards of care for people with spinal muscular atrophy in the UK. Front Neurol 2022; 30: 13.","journal-title":"Front Neurol"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurol.2022.12.003"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.3233\/JND-190424"},{"key":"e_1_3_3_17_2","unstructured":"Health UGOSIoC. SMA REACH UK [Available from: https:\/\/smareachuk.org\/."},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.26419"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-017-0790-9"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.27404"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25900"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.3233\/JND-230211"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/ene.16309"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12051920"},{"key":"e_1_3_3_25_2","unstructured":"Authority THR. UK SMA Patient Registry 2024 [Available from: https:\/\/www.hra.nhs.uk\/planning-and-improving-research\/application-summaries\/research-summaries\/uk-sma-patient-registry\/."},{"key":"e_1_3_3_26_2","unstructured":"Network T-NN. (SMA) Core Dataset 2020 [Available from: https:\/\/www.treat-nmd.org\/what-we-do\/core-datasets\/sma\/#1691758694022-b69614f9-73bf."},{"key":"e_1_3_3_27_2","unstructured":"Authority HR. UK Policy Framework for Health and Social Care Research 2023 [Available from: https:\/\/www.hra.nhs.uk\/planning-and-improving-research\/policies-standards-legislation\/uk-policy-framework-health-social-care-research\/uk-policy-framework-health-and-social-care-research\/."},{"key":"e_1_3_3_28_2","unstructured":"Agency EM. ICH E6 (R2) Good clinical practice - Scientific guideline 2023 [Available from: https:\/\/www.ema.europa.eu\/en\/ich-e6-r2-good-clinical-practice-scientific-guideline."},{"key":"e_1_3_3_29_2","unstructured":"legislation.gov.uk. Data Protection Act 2018 [Available from: https:\/\/www.legislation.gov.uk\/ukpga\/2018\/12\/contents\/enacted."},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(25)00048-0"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-021-01806-4"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2010.202473"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-020-1339-3"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-019-1052-2"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/pds.4932"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/pds.4962"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-022-01768-6"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-024-02440-x"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0266462323000478"},{"key":"e_1_3_3_40_2","unstructured":"Association BM. An NHS under pressure 2024 [Available from: https:\/\/www.bma.org.uk\/advice-and-support\/nhs-delivery-and-workforce\/pressures\/an-nhs-under-pressure."},{"key":"e_1_3_3_41_2","unstructured":"Research NIfHaC. CRN Portfolio [Available from: https:\/\/www.nihr.ac.uk\/researchers\/i-need-help-to-deliver-my-research\/crn-portfolio."},{"key":"e_1_3_3_42_2","unstructured":"HUB B. [Available from: https:\/\/bmd-hub.org\/."},{"key":"e_1_3_3_43_2","unstructured":"HUB D. [Available from: https:\/\/dmdhub.org\/."},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-019-0998-4"},{"key":"e_1_3_3_45_2","unstructured":"Agency EM. Real-world evidence framework to support EU regulatory decision-making. 2023."},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-02160-z"},{"issue":"372","key":"e_1_3_3_47_2","article-title":"STaRT-RWE: structured template for planning and reporting on the implementation of real world evidence studies","volume":"12","author":"Wang SV","unstructured":"Wang SV, Pinheiro S, Hua W, et al. STaRT-RWE: structured template for planning and reporting on the implementation of real world evidence studies. Br Med J 2021; 12(372): m4856.","journal-title":"Br Med J"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1080\/21678707.2023.2241347"}],"container-title":["Journal of Neuromuscular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/22143602261433509","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/22143602261433509","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/22143602261433509","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:32:15Z","timestamp":1793262735000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/22143602261433509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,13]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["10.1177\/22143602261433509"],"URL":"https:\/\/doi.org\/10.1177\/22143602261433509","relation":{},"ISSN":["2214-3599","2214-3602"],"issn-type":[{"value":"2214-3599","type":"print"},{"value":"2214-3602","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,13]]}}}